The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide

@article{Laurentiis2010TheHE,
  title={The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide},
  author={Andrea De Laurentiis and Javier Fern{\'a}ndez-Solari and Claudia Ester Mohn and Berenice Burdet and Mar{\'i}a Aurelia Zorrilla Zubilete and Val{\'e}ria Rettori},
  journal={Journal of Neuroimmunology},
  year={2010},
  volume={221},
  pages={32-41},
  url={https://api.semanticscholar.org/CorpusID:12899399}
}

Figures from this paper

Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge

Which actors and molecular mechanisms are involved in the regulation of the synthesis and secretion of hormones and neurotransmitters and the production of cytokines and other proinflammatory mediators are explored.

Participation of hypothalamic CB1 receptors in reproductive axis disruption during immune challenge

It is suggested that, in male rats, eCB mediate immune challenge‐inhibitory effects on reproductive axis at least partially via hypothalamic CB1 activation, and this receptor also participates in homeostasis recovery by modulating the inflammatory process taking place after LPS administration.

Role of the endocannabinoid system in the neuroendocrine responses to inflammation.

A detailed overview of the current understanding of the role of the endocannabinoid system in the recovering of homeostasis as well as potential pharmacological therapies based on the manipulation of endoc cannabinoidoid system components that could provide novel treatments for a wide range of disorders are provided.

Participation of the Endocannabinoid System in the Effect of TNF‐α on Hypothalamic Release of Gonadotropin‐Releasing Hormone

The data demonstrate a key role for the endocannabinoid system in the response of the reproductive system to inflammatory signals and support the hypothesis that TNF‐α inhibits LHRH release, acting at least in part by activating theendocannabinoids system.

Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes.

It is suggested that alpha-MSH, through MC4R activation, attenuates LPS/IFN-gamma-induced inflammation by decreasing iNOS and COX-2 expression and prevents LPS/(IFN)gammas-induced apoptosis of astrocytes by modulating the expression of proteins of the Bcl-2 family.

Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.

Intracerebroventricular injection of anandamide or THC increased significantly the serum levels of ACTH and corticosterone in a dose-dependent manner and caused a pronounced depletion of CRF-41 in the median eminence, suggesting that anandamia parallels THC in activating the HPA axis via mediation of a central mechanism which involves the secretion of CRf-41.

The role of endocannabinoids in the hypothalamic regulation of visceral function.

It is suggested that the endocannabinoid system is playing an important part in the regulation of the mentioned visceral functions and it provides the bases for further applications of cannabinoid receptor agonists and/or antagonists in visceral diseases regulated by the hypothalamus.

Nitric Oxide at the Crossroad of Immunoneuroendocrine Interactions

The wide participation of NO in the cross‐talk between neuroendocrine and neuroimmune systems in physiological and pathological processes is described.

Presynaptic actions of endocannabinoids mediate alpha-MSH-induced inhibition of oxytocin cells.

We recently showed that central injections of alpha-melanocyte-stimulating hormone (alpha-MSH) inhibits oxytocin cells and reduces peripheral release of oxytocin, but induces oxytocin release from
...